Condition: Cancer · Sponsor: Shu Mei Kato
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blood or urine provided, discarded biological samples taken during routine care that would normally be disposed of and not saved, or on blood samples collected for this study. These research tests will be used to create a "profile" of the collected specimens which will describe unique characteristics about the genes involved in a person's cancer. The tests will also help researchers look for biomarkers that may help predict how people respond to treatment.
This description comes directly from the study's public registry record.
Lee Suzanna, MPH · (858) 534-1306 · sml012@health.ucsd.edu
Michaela Doering, BS · (858) 657-7512 · mdoering@health.ucsd.edu
Always discuss trial participation with your own doctor first.
| UCSD Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Eisenhower Medical Center, Lucy Curci Cancer Center | Rancho Mirage, California, United States | Recruiting |
| Rady Children's Hospital, San Diego | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02478931